Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?
Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Multiple sclerosis drugs: Sticker shock.
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
The Effects of Pranayama, Hatha and Raja Yoga on Physical Pain and the Quality of Life of Women with Multiple Sclerosis.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
Fecundity in women with multiple sclerosis: an observational mono-centric study.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Behavioral and monoamine perturbations in adult male mice with chronic inflammation induced by repeated peripheral lipopolysaccharide administration.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Measurement and maintenance of reserve in multiple sclerosis.
CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.

Pages